Danaher Corporation

$200.56
(as of Mar 31, 10:31 AM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Danaher Corporation

Stock Price
$200.56
Ticker Symbol
DHR
Exchange
NYSE

Industry Information for Danaher Corporation

Sector
Healthcare
Industry
Diagnostics & Research

Company Description for Danaher Corporation

Country
USA
Full Time Employees
61,000

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. Its Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District Of Columbia.

Fundamentals for Danaher Corporation

Market Capitalization
$147,275,382,784
EBITDA
$7,505,999,872
Dividends per Share
$1.08
P/E Ratio
38.91
Forward P/E Ratio
27.03
Earnings per Share
$5.29
Earnings per Share Estimate Next Year
Profit Margin
16.33%
Shares Outstanding
715,449,984
Percent Owned by Insiders
11.04%
Percent Owned by Institutions
82.21%
52-Week High
52-Week Low

Technical Indicators for Danaher Corporation

50-Day Moving Average
200-Day Moving Average
RSI
41.19
4.83

Analyst Ratings for Danaher Corporation

Strong Buy
18
Buy
5
Hold
5
Sell
0
Strong Sell
0

News About Danaher Corporation

Mar 29, 2025, 4:26 PM EST
We recently published a list of Top 10 Stocks to Buy According to Akre Capital Management. See more.
Mar 28, 2025, 5:06 AM EST
Let’s dig into the relative performance of Bio-Techne (NASDAQ:TECH) and its peers as we unravel the now-completed Q4 research tools & consumables earnings season. See more.
Mar 27, 2025, 6:45 AM EST
President Trump is applying the brakes to the profit engines of global automakers. See more.
Mar 24, 2025, 2:15 PM EST
We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. See more.